Preliminary pharmacokinetics and in vivo studies indicate analgesic and stress mitigation effects of a novel NMDA receptor modulator
Blaise M. Costa,
Nakia Phillip,
Seth C. Boehringer
et al.
Abstract:3.AbstractNMDA receptor (NMDAR) channel blockers, which produce analgesic and anti-depressant effects, preferentially block the GluN2D subtype of NMDAR at lower doses. Based on the knowledge of GluN2 subunit physiology, we hypothesized that compounds that concurrently modulate GluN2A and GluN2D subtypes of NMDARs to opposite directions can be useful analgesic and stress-mitigating agents. In this translational study, we explored in vivo activities of a recently discovered glutamate concentration-dependent NMDA… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.